AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05393076 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Linerixibat
Description: Linerixibat dose and administration as per study intervention.
Study NCT05614713 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Selected physical therapy program
Description: Gait training and balance training
Study NCT05614713 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Modified physical therapy program to increase sensory input
Description: Gait training and balance training using sensory stimulating matts
Study NCT06127706 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: twin vaginal delivery simulation
Description: skill test after formal lecture and simulation in group 1 and after digital learning only
Study NCT06215222 — intervention group
Intervention type: OTHER
Intervention: Microbiota Sampling
Description: We will sample the Saliva, Feces, and intestinal microbiome for genetic microbiome analysis and bacterial isolation
Study NCT06412419 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Magnifying Endoscopy and Endoscopic Ultrasonography
Description: The acquired magnifying endoscopy and endoscopic ultrasonography images were shared with artificial intelligence for machine learning, diagnostic modeling and optimization. In the real world evaluation phase, the high-risk population of early esophageal cancer who planned to undergo esophageal electronic endoscopy were prospectively enrolled. The artificial intelligence-assisted diagnosis system was used for prediction before surgery, and the postoperative pathological results were used as the gold standard to diagnose by grouping.
Study NCT04377334 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MSC
Description: infusion of allogeneic bone marrow-derived human mesenchymal stem (stromal) cells
Study NCT05025735 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10Mg Tab
Description: Hyperglycemia is an expected effect of PI3K inhibitors given the pivotal role of PI3K in mediating the response to insulin in multiple tissues. Blocking insulin signaling by p110α inhibitors leads to glycogen breakdown in the liver along with decreased glucose uptake in peripheral tissues. The resulting hyperglycemia causes a compensatory response of increase insulin secretion by the pancreas.~If concurrent treatment with dapagliflozin can abrogate the alpelisib induced hyperglycemia and subsequent rebound hyperinsulinemia it may significantly improve the therapeutic efficacy of alpelisib.
Study NCT06716827 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Home-bleaching
Description: The whitening trays were custom-made for the fixed appliance patients, and they used them for 2-4 hours each evening after brushing their teeth. In the transparent aligner group, whitening was done using the aligners worn for treatment.
Study NCT06716827 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Control
Description: This group of patients did not undergo any whitening procedures.
Study NCT06716047 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Oral administration
Description: Take it directly
Study NCT06716047 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Oral administration
Description: Take it directly
Study NCT04488224 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Nano-X Patient Rotation System
Description: The Nano-X prototype is a horizontal patient rotation system that immobilises participants while being rotated on the horizontal axis.~This device will be used to rotate patients horizontally while cone-beam Computed Tomography (CBCT) projections are acquired.
Study NCT04488224 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Conventional CBCT scan
Description: A conventional cone-beam Computed Tomography (CBCT) scan is acquired on standard radiotherapy machinery.
Study NCT04488224 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Psychometrically validated questionnaires
Description: The Claustrophobia Questionnaire (CLQ), Short Form State/Trait Anxiety inventory (STAI) and Fast Motion Sickness (FMS) questionnaires administered. CLQ only once before the first session, STAI and FMS both before and after each Nano-X CBCT session.
Study NCT06715553 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: BALANCE Program (Body, Art, Learning, Activities, Nutrition, Creativity, and Education)
Description: Six types of intervention will be done on the patients as follows:~* Psychoeducational intervention program~* Art therapy program~* Bibliotherapy program~* Nutrition program~* Sport activity~* Ping Pong activity
Study NCT06714890 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Electrical Stimulation
Description: Transcranial Electrical Stimulation Combined with Accommodation-related Visual Training
Study NCT06714890 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Visual Training
Description: Accommodation-related Visual Training
Study NCT05193006 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: No intervention
Study NCT05059951 — intervention group
Intervention type: DRUG
Intervention: Immune checkpoint inhibitor
Description: Chemotherapy follow the guild line.
Study NCT04658420 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ketamine Hydrochloride
Description: Individuals in the ketamine group will receive ketamine 0.5 mg/kg infused over 40 minutes
Study NCT04658420 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Music
Description: A playlist by composer Nils Frahm will be played for 60 minutes. The music is instrumental, relaxing and subjectively thought to be uplifting by patients who have listened to the music during ketamine infusions performed previously by the PI for treatment of resistant depression. Music can be previewed at the link below:~https://open.spotify.com/playlist/37i9dQZF1DWVbGPBkXJYHF
Study NCT04791267 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Community Health Navigator Program
Description: Patients will be matched to a community health navigator (CHN) who will conduct a needs assessment to determine the frequency of meetings. A CHN may perform any of the following: providing information to a patient's health care provider, translation, advocating for the patient, connecting the patient with resources (e.g., social, financial, insurance), helping patients set health-related goals, facilitating health care referrals and appointments, and monitoring appointments. These activities may require the CHN to be physically present at appointments or have direct contact with the patient's health care provider. Goal setting and support will be provided in-person or over the telephone using motivational interviewing principles.
Study NCT04791267 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Community Health Navigator Program
Description: Patients will be matched to a community health navigator (CHN) who will conduct a needs assessment to determine the frequency of meetings. A CHN may perform any of the following: providing information to a patient's health care provider, translation, advocating for the patient, connecting the patient with resources (e.g., social, financial, insurance), helping patients set health-related goals, facilitating health care referrals and appointments, and monitoring appointments. These activities may require the CHN to be physically present at appointments or have direct contact with the patient's health care provider. Goal setting and support will be provided in-person or over the telephone using motivational interviewing principles.
Study NCT05024877 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hetrombopag
Description: Hetrombopag would be given started with 5mg/day and increased by 2.5mg/day every 2 weeks if the platelet count remains less than 20×10e9/L and reduced if the platelet count reaches over than 150×10e9/L, the maximum dosage is 15mg/day)
Study NCT05024877 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Stanozolol Tablets
Description: Stanozolol would be given 2mg tid.
Study NCT02814864 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mesenchymal Stromal Cell (MSC) injections
Description: 12 patients suffering of PRD (LENT-SOMA scale>2) will receive Mesenchymal Stromal Cell (MSC) injections
Study NCT06060756 — intervention group
Intervention type: OTHER
Intervention: questionnaires completion
Description: Patients will complete the following questionnaires at 3, 6 and 12 months after start of the treatment for Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS):~* Pain-related questionnaire~* Endometriosis-specific questionnaire~* Hospital Anxiety and Depression scale~* Questionnaire McGill on Quality Of Life~* Insomnia-related questionnaire
Study NCT05147974 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: DOZE app
Description: Complete DOZE app: Delivering Online ZZZ's with Empirical support (DOZE) app plus a Consensus Sleep Diary (CSD).~The DOZE app, is a web-based app optimized for desktop, smartphone, or tablet use. It is a self-management program for adolescents and young adults with sleep problems. The intervention will be delivered on restricted password-protected applications that will allow tracking of adherence (number of logins to app and website using Google Analytics). Participants will be encouraged to log onto the sleep dairy (via automated alerts) once a day over a 10-week period to complete sleep diary entries, develop and track their goals, and receive sleep health education/tailored sleep health interventions.~1-week pre- and post- intervention, participants will complete a battery of baseline study questionnaires and have the option of using a Geneactiv actigraphy device along with a CSD.
Study NCT05060783 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: GaGnostic
Description: Plasma
Study NCT05060783 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: GaGnostic
Description: Serum
Study NCT05060783 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: GaGnostic
Description: Urine
Study NCT05494749 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: zirconomer
Description: teeth meeting the inclusion criteria are assigned to receive Zirconomer® restorations
Study NCT05494749 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: HVGI-Equia Forte
Description: teeth meeting the inclusion criteria are assigned to receive HVGI-Equia Forte® restorations.
Study NCT05352906 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Intraocular pressure
Description: Measurements of intraocular pressure in millimeter mercury (mmHg).
Study NCT05812339 — intervention group
Intervention type: DEVICE
Intervention: Gastric Alimetry System
Description: Gastric Alimetry is a medical device intended to record, store, view and process gastric myoelectrical activity as an aid in the diagnosis of gastrointestinal motility disorders. The device is indicated for use during the diagnostic work-up of patients reporting gastric symptoms, who are suspected of having an underlying gastric motility problem.
Study NCT05393245 — intervention group
Intervention type: DRUG
Intervention: Tiotropium+Olodaterol
Description: Tiotropium+Olodaterol
Study NCT05393245 — intervention group
Intervention type: DEVICE
Intervention: Spiolto Respimat
Description: Spiolto Respimat Inhaler device
Study NCT05393245 — intervention group
Intervention type: DRUG
Intervention: Long-acting muscarinic antagonists (LAMAs)
Description: Long-acting muscarinic antagonists (LAMAs)
Study NCT05393245 — intervention group
Intervention type: DRUG
Intervention: Long-acting β2-agonists (LABAs)
Description: Long-acting β2-agonists (LABAs)
Study NCT06062017 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Water and Potassium supplementation
Description: All Participants will be given cases of water and instructed to drink at least an extra 1L per day. Additionally, participants will be given 2000 mg of potassium via potassium citrate powder.
Study NCT05056896 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aspirin
Description: Capsule taken orally
Study NCT04993898 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Plyometric training with warm up and cool down
Description: These Include Squat to Squat Jump, Lunge to Plyo Lunge, Step Jack to Star Jumps, Plank to Plyo Spider Lunge, Plank to Frogger Frequency = 2 days per week for 2 weeks and then 4 days per week after 2nd week to 4th week Intensity =500 jumps Time = 30 min
Study NCT04993898 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional training with warm up & cool down
Description: These include Squats, Single leg squat, Cork hip lift, Press ups, Normal warm-up time 15 min before game.
Study NCT05583253 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Vitrectomy
Description: Small gauge pars-plana vitrectomy for management of retinal detachment.
Study NCT01566916 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Total Hip Arthroplasty
Study NCT04861233 — intervention group
Intervention type: OTHER
Intervention: No Intervention
Description: This is a non-interventional study.
Study NCT05184361 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intermittent energy restriction (IER)
Description: Both groups will be accompanied by a registered dietitian in order to provide an individual and personalized diet plan that will suppress the respective daily requirements for each phase. Macronutrient distribution will be the following: 35% protein, 35% carbohydrate and 30% fat.~Daily energy requirements (DER) will be calculated by multiplying measured RMR (through indirect calorimetry) by physical activity level (PAL), assessed by accelerometry.~In order to achieve a neutral EB, 100% of their daily energy requirements (DER) will be prescribed for each participant. For both groups, an energy restriction of 33% of one's DER will be created. The IER group will alternate between 2-weeks in energy restriction (67% DER) and 1-week in neutral EB (100% DER), in a total of 23-weeks.~The IER group will alternate between 2-weeks in energy restriction (67% DER) and 1-week in neutral EB (100% DER), in a total of 23-weeks.
Study NCT05184361 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Continuous energy restriction (CER)
Description: A dietary plan comprising 67% of DER will be prescribed to the CER group. Participants will be asked to follow this plan in a total of 16-weeks, without interruptions.
Study NCT05107024 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: RFR-guided step by step balloon dilation
Description: The mean value of the minimum ratio of distal mean pressure to aortic mean pressure (Pd/Pa) in five consecutive complete cardiac cycles was obtained by scanning the diastolic and systolic stages at rest.
Study NCT05107024 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Traditional balloon dilation
Description: The surgeon determines the optimal size of the semi-compliant balloon based on angiography (balloon to vessel ratio 1.0) and performs adequate predilation to achieve residual stenosis. 30% of vascular anatomy criteria
Study NCT04961749 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Whole body vibration training
Description: Whole-body vibration training applies a vibration stimulus to an individual as they are standing on a side-alternating platform. The vibration creates small muscle contractions in the lower extremity musculature which has been shown to improve function and ambulatory function.
Study NCT06124066 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Mirabegron 50 MG
Description: The participants were given mirabegron 50 mg or tamsulosin 0.4 mg and filled in the Ureteral Stent Symptom Questionnaire (USSQ), filled in directly when the patient arrived or by telephone.
Study NCT06124066 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Mirabegron 50 MG
Description: The participants were given mirabegron 50 mg or tamsulosin 0.4 mg and filled in the Ureteral Stent Symptom Questionnaire (USSQ), filled in directly when the patient arrived or by telephone.
Study NCT04618757 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Hedonic Reward
Description: A reimbursement credit for hedonic expenses worth up to $50 will be awarded to each participant if they log at least 10,000 daily steps on at least 25 days during the first 28 days of each calendar month on Fitbit activity trackers provided by the study.
Study NCT04618757 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cash Reward
Description: A reimbursement credit for $50 in cash will be awarded to each participant if they log at least 10,000 daily steps on at least 25 days during the first 28 days of each calendar month on Fitbit activity trackers provided by the study.
Study NCT04618757 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Fitbit
Description: Fitbit devices are wireless pedometers that track the steps of participants, and will be offered in conjunction with a tailored website with customized information for participants.
Study NCT05056896 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Capsule taken orally
Study NCT05678023 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Effect on contrast media depending on the time of its administratsion
Description: CM is a common practice when it comes to the management of small bowel obstruction. However there is no consensus as when it should be administered
Study NCT05849311 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Envafolimab with new manufacturing process
Description: Dosage form:~Envafolimab is a monoclonal antibody drug administered subcutaneously in a minimum packaging unit of 1.0 ml solution in a single-use glass vial containing a total of 200 mg of Envafolimab.~Treatment method:~Envafolimab, single dose, 1 mg/kg, subcutaneously.
Study NCT05849311 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Envafolimab with old manufacturing process
Description: Dosage form:~Envafolimab is a monoclonal antibody drug administered subcutaneously in a minimum packaging unit of 1.0 ml solution in a single-use glass vial containing a total of 200 mg of Envafolimab.~Treatment method:~Envafolimab, single dose, 1 mg/kg, subcutaneously.
Study NCT04848233 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: OTHER
Intervention: Drinks containing 5AA+CrPic and Placebo
Description: Same diet will be repeated for 3 days in a row and the beverage switched every day. 3 periods of 3 days are included in the study.
Study NCT05782179 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: GBS-NN/NN2
Description: GBS-NN/NN2 bound to alhydrogel as an adjuvant
Study NCT05782179 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Normal Saline 0.9 %
Study NCT04699071 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: pembrolizumab and lenvatinib
Description: All patients will receive oral lenvatinib daily plus intravenous pembrolizumab 3-weekly.~A cycle is 21 days. Allowances will be made for stepwise dose reductions of lenvatinib due to treatment-related toxicities.~Toxicity will be assessed according to the National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events, (CTCAE) Version 5.0.~Patients are planned to continue therapy until disease progression, intolerable toxicity, or withdrawal of patient consent.
Study NCT05596903 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EMDR 2.0 group protocol
Description: EMDR 2.0 group protocol
Study NCT05596903 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Mhgap stress module
Description: Mhgap stress module
Study NCT06308640 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Insertion of the device intraorally
Description: * The distalizer appliance will be checked for adaptation intraorally, the two bands of the maxillary first molars will be fitted in their accurate position on the teeth.~* The screw insertion will be carried out with the patient under local anesthesia.~* They will be placed inside the two eyelets of the anterior arms of the screw in the appliance
Study NCT06489938 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Impairment-oriented approach
Description: The impairment-oriented approach will focus on the movement components. Arm BASIS or Arm Ability training will be provided based on the severity of the participant's impairment.
Study NCT06489938 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Impairment-oriented approach
Description: The impairment-oriented approach will focus on the movement components. Arm BASIS or Arm Ability training will be provided based on the severity of the participant's impairment.
Study NCT04730362 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: guedel airway
Description: Anesthesia will be conducted by induction with 1-2~• Mg/kg of an IV propofol bolus and then anesthesia is maintained with an inhalational anesthesia with sevoflurane 2%-4%. The goal is to maintain the patient spontaneous ventilation throughout the procedure. Monitoring of the patients is done by MRI compatible pulse oximetry for heart rate and oxygen saturation which is connected to MRI control room.
Study NCT04730362 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: supraglottic airway
Description: supraglottic airway
Study NCT04730362 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: propofol bolus and then anesthesia sevoflurane
Description: Mg/kg of an IV propofol bolus and then anesthesia is maintained with an inhalational anesthesia with sevoflurane 2%-4%
Study NCT05310994 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo drink
Description: consume 1 bottle per day
Study NCT05310994 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Wasabi Leaf Extract Drink
Description: consume 1 bottle per day
Study NCT05298644 — intervention group
Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: VLA2001
Description: whole virus inactivated SARS-CoV-2 vaccine adjuvanted with cytosine phospho-guanine (CpG)1018 in combination with aluminium hydroxide